A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma

NCT04203797 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: dupilumab
DRUG: Matching placebo

Sponsor

Regeneron Pharmaceuticals